58 results
424B3
FOXO
FOXO Technologies Inc - Ordinary Shares
30 Oct 23
Prospectus supplement
6:30am
the underwriting process and provide a more personalized risk assessment. The Longevity Report, sales of which have also been paused as we redevelop … such as the Physicians’ Health Study. Our analyses of these data are intended to inform the utility and capabilities of epigenetics for health assessment
424B3
FOXO
FOXO Technologies Inc - Ordinary Shares
6 Sep 23
Prospectus supplement
5:13pm
and provide a more personalized risk assessment. The Longevity Report, sales of which have also been paused as we redevelop and restrategize around this product … assessment.
While we believe these research projects will lead to the discovery, improvement, and commercialization of our proprietary epigenetic
424B3
fk6jmvqmqq0nkksmzz6
10 Aug 23
Prospectus supplement
6:01pm
424B3
sq5kfm1y
10 Aug 23
Prospectus supplement
6:00pm
424B3
ju9k2m k2a0
10 Aug 23
Prospectus supplement
5:58pm
424B3
hz7ii s7lmv
3 Aug 23
Prospectus supplement
5:05pm
424B3
6wk0qgls32qj8 idwie
20 Jul 23
Prospectus supplement
7:22pm
424B3
8rsbekhhkctud4ggakn
20 Jul 23
Prospectus supplement
7:19pm
8-K
EX-10.2
dn59ljjlc
20 Jul 23
Entry into a Material Definitive Agreement
4:54pm
424B3
52dj4u
6 Jul 23
Prospectus supplement
5:22pm
424B3
m8egxowkcr0d2opw
30 May 23
Prospectus supplement
8:56am
8-K
EX-10.5
awef8 fc5oxwyf4
30 May 23
Entry into a Material Definitive Agreement
8:53am